Kosty MP - Search Results

1

Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B.

Kosty MP, Fleishman SB, Herndon JE 2nd, Coughlin K, Kornblith AB, Scalzo A, Morris JC, Mortimer J, Green MR. Kosty MP, et al. J Clin Oncol. 1994 Jun;12(6):1113-20. doi: 10.1200/JCO.1994.12.6.1113. J Clin Oncol. 1994. PMID: 8201372 Clinical Trial.

2

A longitudinal study of quality of life in advanced non-small cell lung cancer: Cancer and Leukemia Group B (CALGB) 8931.

Herndon JE 2nd, Fleishman S, Kosty MP, Green MR. Herndon JE 2nd, et al. Among authors: kosty mp. Control Clin Trials. 1997 Aug;18(4):286-300. doi: 10.1016/0197-2456(96)00116-x. Control Clin Trials. 1997. PMID: 9257067 Clinical Trial.

3

Placebo-controlled randomized study of hydrazine sulfate in lung cancer.

Kosty MP, Herndon JE 2nd, Green MR, McIntyre OR. Kosty MP, et al. J Clin Oncol. 1995 Jun;13(6):1529-30. doi: 10.1200/JCO.1995.13.6.1529. J Clin Oncol. 1995. PMID: 7751903 Clinical Trial. No abstract available.

4

Nonoperative management of non-small cell lung cancer: the current cancer and leukemia group B experience.

Green MR, Kosty MP, Muscato JJ, Graziano S, Dillman RO, Clamon GH, Herndon J 2nd. Green MR, et al. Among authors: kosty mp. Semin Oncol. 1994 Jun;21(3 Suppl 6):60-5. Semin Oncol. 1994. PMID: 8052875 Review.

5

Outcomes among African-American/non-African-American patients with advanced non-small-cell lung carcinoma: report from the Cancer and Leukemia Group B.

Blackstock AW, Herndon JE 2nd, Paskett ED, Perry MC, Graziano SL, Muscato JJ, Kosty MP, Akerley WL, Holland J, Fleishman S, Green MR. Blackstock AW, et al. Among authors: kosty mp. J Natl Cancer Inst. 2002 Feb 20;94(4):284-90. doi: 10.1093/jnci/94.4.284. J Natl Cancer Inst. 2002. PMID: 11854390

6

Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma?

Herndon JE 2nd, Fleishman S, Kornblith AB, Kosty M, Green MR, Holland J. Herndon JE 2nd, et al. Cancer. 1999 Jan 15;85(2):333-40. doi: 10.1002/(sici)1097-0142(19990115)85:2<333::aid-cncr10>3.0.co;2-q. Cancer. 1999. PMID: 10023700 Clinical Trial.

7

Therapy choices among older patients with lung carcinoma: an evaluation of two trials of the Cancer and Leukemia Group B.

Rocha Lima CM, Herndon JE 2nd, Kosty M, Clamon G, Green MR. Rocha Lima CM, et al. Cancer. 2002 Jan 1;94(1):181-7. doi: 10.1002/cncr.10174. Cancer. 2002. PMID: 11815975 Free article. Clinical Trial.

8

High-dose doxorubicin, dexrazoxane, and GM-CSF in malignant mesothelioma: a phase II study-Cancer and Leukemia Group B 9631.

Kosty MP, Herndon JE 2nd, Vogelzang NJ, Kindler HL, Green MR. Kosty MP, et al. Lung Cancer. 2001 Nov;34(2):289-95. doi: 10.1016/s0169-5002(01)00250-1. Lung Cancer. 2001. PMID: 11679188 Clinical Trial.

9

Cladribine and mitoxantrone dose escalation in indolent non-Hodgkin's lymphoma.

Saven A, Lee T, Kosty M, Piro L. Saven A, et al. J Clin Oncol. 1996 Jul;14(7):2139-44. doi: 10.1200/JCO.1996.14.7.2139. J Clin Oncol. 1996. PMID: 8683247

10

Comparison of psychosocial adaptation and sexual function of survivors of advanced Hodgkin disease treated by MOPP, ABVD, or MOPP alternating with ABVD.

Kornblith AB, Anderson J, Cella DF, Tross S, Zuckerman E, Cherin E, Henderson ES, Canellos GP, Kosty MP, Cooper MR, et al. Kornblith AB, et al. Among authors: kosty mp. Cancer. 1992 Nov 15;70(10):2508-16. doi: 10.1002/1097-0142(19921115)70:10<2508::aid-cncr2820701020>3.0.co;2-v. Cancer. 1992. PMID: 1384949 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

70 results

Search Page